$URGN Income Statement | Understand Stock

$URGN

$33.91 -$0.13 (0.38%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development expenses
Selling, general and administrative expenses
Operating loss
Financing on prepaid forward obligation
Interest expense on long-term debt
Interest and other income, net
Loss before income taxes
Income tax expense
Net Loss
Other comprehensive loss
Unrealized income (loss) on investments
Comprehensive Loss
Loss per ordinary share basic and diluted (in dollars per share)
Net loss per ordinary share - basic and diluted (in dollars per share)
Weighted average number of shares outstanding used in computation of basic and diluted loss per ordinary share (in shares)

Comments